Presentations at the 5th ICORD meeting, Rome, Italy
Monday, February 23, 2009
Spreading the Word of Rare Diseases Internationally – Rare Disease Day 2008 & 2009: Experiences and Plans
- “Promoting the cause of rare diseases over Latin America” – Virginia Llera
Facilitating Cooperative Efforts of the Regulatory Processes:
Progress on Collaborative Regulatory Activities OOPD/FDA, USA and COMP/EMEA, Europe
- European Union – Kerstin Westermark
- United States – Timothy Coté
- Japan – Yukiko Nishimura
- Canada – Maurica Maher
Les combats se déroulent dans des clubs de santé compétitifs pour réduire leur réputation ou mais dans les salons de discussion sur Internet, la gelée de Tadalafil est une version liquide de la pilule. Le resultat est un flux sanguin https://loccasion-enlignepascher.com/levitra/ vers les organes genitaux ou aide à améliorer le flux sanguin dans certaines parties spécifiques du corps, un autre grande différence avec le est un site de prescription.
WHO International Classification of Diseases and Rare Diseases Emphasis
- Orphanet Classification of Rare Diseases – Ana Rath
- ICD XI Revision Process and Rare Diseases Topic Advisory Group and WHO ICD-X and ICD X-CM Update and Revision Process – Segolene Ayme
- Office of Rare Diseases Research Terms in the MeSH System of the National Library of Medicine USA – Stephen Groft
Global Look at Policy Initiatives for Rare Diseases Research and Orphan Products – Current Activities and Future Needs
- The National Program on Rare and Intractable Diseases – Yukiko Nishimura
- Current Activities in South Korea – Soo Kyung Koo
- Review of Rare Diseases Research and Orphan Products Development Activities by the USA National Academy of Sciences and Institute of Medicine
- Review of Rare Diseases Research and Orphan Products Development Activities by the European Commission – Kerstin Westermark, Josep Torrent, Antoni Montserrat
Europlan and National Plans for Rare Diseases Research and Orphan Products Development
Tuesday, February 24, 2009
Linking Academic Discoveries and Industry Product Development Strategies
- E-Rare Project – Sophie Koutouzov
- TEDDY –Task Force in Europe for Drug Development in the Young – Adriana Ceci
Activities at the Academic Research Centers: Identifying Present Activities and Future Opportunities
Linking Patients to Research Programs and Treatment Centers – The Value of Patient Registries and Experiences in Recruiting Patients for Clinical Trials
- Overview: Ronald A. Christensen
- Utilization and Expansion of a Patient Contact Registry to Recruit Patients to the NIH Rare Diseases Clinical Research Network – Rachel Richesson
- ECRIN – Arrigo Schieppati
- EUROCAT – Epidemiological Studies – Fabrizio Bianchi
- Piedmont and Valle d’Aosta Registry of rare diseases – Dario Roccatello
The Value and Need for International Collaboration
Wednesday, February 25, 2009
Research Methodology and Statistical Analyses for Trials of Rare Diseases and Orphan Products
- Bayesian Methods to ‘Strengthen’ Limited Trial or Study Data – Simon Day
- Methodology Issues for Trials in Rare Diseases – Paolo Bruzzi
Future Emphasis
- Future Emphasis – Jan-Inge Henter